BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Abdominal Aortic Aneurysm |
📓
Dual pathogen valvular endocarditis in a case of severe aortic aneurysm. Autopsy & case reports (Autops Case Rep ) Vol: 12 Issue Pages: e2021381 Pub: 2022 Epub: 2022 May 5 Authors Yadav M , Tewari R , Chatterjee T , Html Article Publication |
| Abdominal Aortic Aneurysm |
📓
Mycotic abdominal aortic aneurysm caused by bacteroides thetaiotaomicron and acinetobacter lwoffii: the first case in Korea. Infection & chemotherapy (Infect Chemother ) Vol: 46 Issue 1 Pages: 54-8 Pub: 2014 Mar Epub: 2014 Mar 21 Authors Kim MG , Jeon JW , Ryu IH , Lee JJ , Kim JS , Choi JW , Cho BS , Yoon HJ , Html Article Publication |
| Abdominal Aortic Aneurysm |
📓
Exploring the Impact of Gut Microbiota on Abdominal Aortic Aneurysm Risk through a Bidirectional Mendelian Randomization Analysis. Journal of vascular surgery (J Vasc Surg ) Vol: Issue Pages: Pub: 2023 Nov 30 Epub: 2023 Nov 30 Authors Zhou X , Ruan W , Wang T , Liu H , Du L , Huang J , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
